Hospital or health organisation · founded 1981
Moffitt Cancer Center
Tampa, United States · moffitt.org
- Citations, last 5 years
- 134.7k
- Works, last 5 years
- 13.7k
- h-index
- 815
- Scientists listed
- 950
- Grants since 2016
- 1 073
Grants received
2021–2026 · research · R01
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis
Florian Karreth · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R37
Role of Sirt2 in T Cell Metabolism
Sungjune Kim · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · program · P01
Identifying Metabolic Vulnerabilities in Lung Cancer
Elsa R Flores · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
HIV Genomic Aging Project in Oncology (HIV-GAP)
Anna Coghill · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R35
New reagents for C-C and C-N bond formation
Justin Matthew Lopchuk · Moffitt Cancer Center · funded by National Institutes of Health
2021–2024 · research · R01
Decoding tobacco-related oral cancer ecosystem by integrative approach
Christine H Chung · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
Shari Pilon-Thomas · Moffitt Cancer Center · funded by National Institutes of Health
2021–2027 · research · R01
Characterizing oncogenic function of ITCH in melanoma
Lixin Wan · Moffitt Cancer Center · funded by National Institutes of Health
2021–2023 · research · R21
Targeting the suppressive immune microenvironment in leptomeningeal melanoma metastases
Keiran Smalley · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers
Derek Ronald Duckett · Moffitt Cancer Center · funded by National Institutes of Health
2021–2023 · research · R21
Developing mathematical model driven optimized recurrent glioblastoma therapies
Heiko Enderling · Moffitt Cancer Center · funded by National Institutes of Health
2021–2024 · career development · K08
Nitric oxide immune dependent resistance mechanisms to anti-PD-1 therapy
Joseph Markowitz · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers
Derek Ronald Duckett · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · grant · DP2
AGING AS A SELECTIVE PRESSURE THAT DRIVES TUMOR PROGRESSION
Ana Da Silva Gomes · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
HIV Genomic Aging Project in Oncology (HIV-GAP)
Anna Coghill · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers
Christine Vinci · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R35
Biophysical basis for enzyme mediated deglycation in protein repair
Jennifer Binning · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Eco-evolutionary drivers of clonal dynamics during UV-induced skin carcinogenesis (PQ3)
Joel Brown · Moffitt Cancer Center · funded by National Institutes of Health
2021–2024 · research · R21
Developing mathematical model driven optimized recurrent glioblastoma therapies
Hsiang-Hsuan Michael Yu · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
HIV Genomic Aging Project in Oncology (HIV-GAP)
Anna Coghill · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
Shari Pilon-Thomas · Moffitt Cancer Center · funded by National Institutes of Health
2021–2025 · research · R01
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells
Jose Alejandro Guevara-Patino · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Radiomics and Pathomics to predict upstaging of DCIS
Mehdi Damaghi · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis
Florian Karreth · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers
Christine Vinci · Moffitt Cancer Center · funded by National Institutes of Health
2021–2023 · research · R37
Role of Sirt2 in T Cell Metabolism
Sungjune Kim · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis
Florian Karreth · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R35
Biophysical basis for enzyme mediated deglycation in protein repair
Jennifer Binning · Moffitt Cancer Center · funded by National Institutes of Health
2021–2024 · career development · K08
Nitric oxide immune dependent resistance mechanisms to anti-PD-1 therapy
Joseph Markowitz · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers
Derek Ronald Duckett · Moffitt Cancer Center · funded by National Institutes of Health
2021–2024 · research · R21
Exploring miR-29 in melanoma progression and prevention
Florian Karreth · Moffitt Cancer Center · funded by National Institutes of Health
2021–2027 · grant · D43
Ghana IntegRative Approach to Cancer ResEarch Training: The Grace Program
Anna R. Giuliano · Moffitt Cancer Center · funded by National Institutes of Health
2021–2025 · research · R01
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells
Jose Alejandro Guevara-Patino · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · program · P01
Identifying Metabolic Vulnerabilities in Lung Cancer
Elsa R Flores · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · program · P01
Identifying Metabolic Vulnerabilities in Lung Cancer
Elsa R Flores · Moffitt Cancer Center · funded by National Institutes of Health
2021–2023 · career development · K99
Spontaneous humoral responses open opportunities for novel immunotherapies against human cancer
Subir Biswas · Moffitt Cancer Center · funded by National Institutes of Health
2021–2025 · research · R01
Targeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms
Gary W Reuther · Moffitt Cancer Center · funded by National Institutes of Health
2021–2025 · research · R01
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells
Jose Alejandro Guevara-Patino · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers
Derek Ronald Duckett · Moffitt Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Characterizing oncogenic function of ITCH in melanoma
Lixin Wan · Moffitt Cancer Center · funded by National Institutes of Health